| Patents for C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294) |
|---|
| 01/08/2014 | CN103497222A Method for extracting isatan from fresh and alive folium isatidis |
| 01/08/2014 | CN101952237B Bromide-free TEMPO-mediated oxidation of the primary alcohol in carbohydrate under two-phase conditions |
| 12/31/2013 | CA2666246C Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 12/26/2013 | US20130344028 1'-substituted carba-nucleoside analogs for antiviral treatment |
| 12/18/2013 | CN101686716B Prebiotics |
| 12/12/2013 | US20130331404 Methods and Compositions for Inhibition of Polymerase |
| 12/11/2013 | CN103443113A Synthesis of new fucose-containing carbohydrate derivatives |
| 12/10/2013 | US8603989 Method for treating and preventing kidney stones employing an SGLT2 inhibitor and composition containing same |
| 12/04/2013 | CN103421061A Lenalidomide derivative and preparation method and pharmaceutical application thereof |
| 12/04/2013 | CN103421057A Combretastatin amino sugar conjugate and preparation method and medical appliance thereof |
| 12/04/2013 | CN102159586B C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof |
| 11/27/2013 | CN103408604A Method for synthesis of calcium alginic acid monosaccharide from shells and alginic acid |
| 11/20/2013 | EP2663314A2 Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases |
| 11/20/2013 | CN103402548A Improved glycan arrays and methods for their fabrication |
| 11/14/2013 | WO2013168007A1 Compositions and methods for the treatment of cardiovascular and neurological diseases |
| 11/13/2013 | CN102260297B Trehalose amide derivative as well as preparation method thereof and application thereof |
| 11/13/2013 | CN101679189B Novel reaction with a gold catalyst |
| 10/17/2013 | WO2013152654A1 Process for preparation of benzylbenzene sodium-dependent glucose cotransporter 2 (sglt2) inhibitors |
| 10/10/2013 | WO2013151428A1 Catalytic oxidation of uronic acids to aldaric acids |
| 10/10/2013 | WO2013068850A8 PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES |
| 10/10/2013 | US20130267694 Process for the preparation of benzylbenzene sglt2 inhibitors |
| 10/03/2013 | US20130261077 Mannose derivatives for treating bacterial infections |
| 09/18/2013 | CN103304602A Dabigatran etexilate gluconate, and preparation method and application thereof |
| 09/11/2013 | CN103288889A Anthraquinone derivatives, their pharmaceutical compositions and application in medicine preparation |
| 09/11/2013 | CN101974038B Oligomeric amino sugar acid and preparation method thereof |
| 08/27/2013 | US8518895 Method for treating hyponatremia employing an SGLT2 inhibitor and composition containing same |
| 08/22/2013 | WO2013068850A3 PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES |
| 08/22/2013 | WO2013064909A3 Crystalline and non-crystalline forms of sglt2 inhibitors |
| 08/20/2013 | US8513202 Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate |
| 08/14/2013 | EP2625181A2 Method of preparation of antiviral compounds and useful intermediates thereof |
| 08/14/2013 | EP2624816A2 Stimulation of neuroregeneration by flavonoid glycosides |
| 08/13/2013 | US8507660 Alpha-selective sialyl phosphate donors for preparation of sialosides and sialoside arrays for influenza virus detection |
| 08/06/2013 | US8501698 Crystal structures of SGLT2 inhibitors and processes for preparing same |
| 08/01/2013 | US20130196935 Synthetic glycoamine compounds |
| 07/30/2013 | US8497064 Nucleic acid labelling compounds |
| 07/25/2013 | US20130190256 Curcumin Derivatives |
| 07/24/2013 | EP2616080A1 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 07/17/2013 | CN102212148B Antithrombotic medicament for intravenous injection and preparation method and application thereof |
| 07/04/2013 | WO2013097042A1 2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation |
| 07/02/2013 | US8476413 Sulfanyl-tetrahydropyran-based compounds and methods of their use |
| 06/27/2013 | US20130165395 Methods of treating diabetes |
| 06/20/2013 | WO2013090550A1 Novel glycoside compounds |
| 06/20/2013 | WO2013089792A1 Bio-based polyols and polymers made therefrom |
| 06/20/2013 | US20130157970 Novel glycoside compounds |
| 06/19/2013 | EP2604612A1 C-aryl glucoside derivatives, preparation rpocess and pharmaceutical use thereof |
| 06/13/2013 | WO2013022238A3 Tricyclic glycosylated derivative compound, a production method therefor, and an immunosuppressant pharmaceutical composition comprising a tacrolimus glycosylation derivative |
| 06/13/2013 | WO2013019050A3 Novel α-glycosyl stevioside, and preparation method thereof |
| 06/12/2013 | CN103153314A 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 06/12/2013 | CN103145773A Crystalline solvates and complexes of (IS) -1, 5-anhydro-L-C- (3- ( (phenyl) methyl) phenyl) -D-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes |
| 06/04/2013 | US8455451 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 05/30/2013 | US20130137646 Methods of treatment, pharmaceutical compositions and uses thereof |
| 05/28/2013 | US8450286 Method for treating cancers having high glucose requirements employing an SGLT2 inhibitor and compositions thereof |
| 05/22/2013 | CN103113427A Fructosevaline preparation method |
| 05/21/2013 | CA2574651C Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives |
| 05/16/2013 | US20130122094 Sialic acid analogs |
| 05/16/2013 | CA2854591A1 Process for the preparation of .beta.-c-aryl glucosides |
| 05/15/2013 | CN101918423B Dipeptidyl peptidase-IV inhibitor |
| 05/10/2013 | CA2852000A1 Crystalline and non-crystalline forms of sglt2 inhibitors |
| 05/08/2013 | CN103087117A Preparation method of high-purity azalomycin B |
| 05/08/2013 | CN101516821B Process for obtaining an organic salt or organic acid from an aqueous sugar stream |
| 05/08/2013 | CN101282984B Immunogens for meningitidis-a vaccines |
| 05/07/2013 | CA2459562C Synthetic heparin pentasaccharides |
| 05/02/2013 | WO2013063149A1 Sialic acid analogs |
| 05/02/2013 | CA2849114A1 Sialic acid analogs |
| 05/01/2013 | CN103073601A Controllable concentration and crystallization method for adding seed crystals to 2-keto-L-gulonic acid solution |
| 04/24/2013 | CN102167715B Eutectic preparation method of sodium-glucose cotransporter 2 bulk pharmaceutical chemicals |
| 04/24/2013 | CN101558077B Manufacturing method of tagatose using galactose isomerization of high yield |
| 04/11/2013 | WO2013050497A1 Process of preparation of l-iduronic acid and derivatives comprising a decarboxylation/intramolecular cyclisation tandem reaction |
| 04/11/2013 | US20130090298 Thiazole Derivatives as SGLT2 Inhibitors and Pharmaceutical Composition Comprising Same |
| 04/10/2013 | EP2578594A1 Process of preparation of L-iduronic acid comprising a decarboxylation/intramolecular cyclisation tandem reaction |
| 04/09/2013 | US8415308 1′-substituted-carba-nucleoside prodrugs for antiviral treatment |
| 04/04/2013 | WO2013044608A1 Anomeric alkyl-containing phenyl c-glucoside derivative, preparation method therefor and use thereof |
| 04/04/2013 | WO2013004377A3 Compositions comprising cellobiose dehydrogenase from pycnoporus cinnabarinus and their use for the degradation of lignocellulosic biomass |
| 04/03/2013 | CN103012507A Synthetic method of 3-deoxidized-D-sweet dew-2-octulosonic ammonium salt |
| 03/28/2013 | US20130079293 Neuro-protective effects of adelostemma gracillimum and its isolated compounds |
| 03/28/2013 | US20130078218 Hepatitis c therapies |
| 03/27/2013 | CN102993241A Preparation method of L-fucose analogues |
| 03/27/2013 | CN101479287B Crystalline solvates and complexes of (is) -1, 5-anhydro-l-c- (3- ( (phenyl) methyl) phenyl) -d-glucitol derivatives with amino acids as sglt2 inhibitors for the treatment of diabetes |
| 03/26/2013 | US8404833 Synthetic heparin disaccharides |
| 03/12/2013 | US8394949 Multisignal labeling reagents, and processes and uses therefor |
| 03/12/2013 | US8394851 Osmoprotective complexes for prevention of mitochondrial free radical damage related skin aging |
| 02/26/2013 | US8383810 Process for the synthesis of azetidinones |
| 02/21/2013 | US20130046088 Processes for the Preparation of SGLT2 Inhibitors |
| 02/21/2013 | US20130045931 Production and use of antibacterial, antiproliferative, and antiphytopathogenic benzanthracenes |
| 02/14/2013 | WO2013022238A2 Tricyclic glycosylated derivative compound, a production method therefor, and an immunosuppressant pharmaceutical composition comprising a tacrolimus glycosylation derivative |
| 02/13/2013 | EP2557086A2 Synthetic heparin pentasaccharides |
| 02/13/2013 | CN102933592A Crystalline form for diphenylmethane sglt2 inhibitor |
| 02/07/2013 | WO2013019050A2 Novel α-glycosyl stevioside, and preparation method thereof |
| 02/07/2013 | US20130034521 1'-substituted carba-nucleoside analogs for antiviral treatment |
| 01/24/2013 | WO2013011459A1 Process for the preparation of fondaparinux |
| 01/17/2013 | US20130017993 Glycoside derivatives and uses thereof |
| 01/15/2013 | CA2706833C Geranyl compounds |
| 01/15/2013 | CA2706826C Geranyl compounds |
| 01/15/2013 | CA2561873C An alginate oligosaccharide and its derivatives, and the preparation and uses thereof |
| 01/10/2013 | WO2013004377A2 Compositions comprising cellobiose dehydrogenase from pycnoporus cinnabarinus and their use for the degradation of lignocellulosic biomass |
| 01/08/2013 | CA2480578C Anomeric derivatives of monosaccharides |
| 01/03/2013 | WO2012140666A3 Herbal extracts and compositions prepared therefrom |
| 12/20/2012 | US20120322974 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds |
| 12/06/2012 | US20120309107 Direct Sensing of Molecular Species by Polyfluors on a DNA Backbone |
| 12/05/2012 | EP2530079A1 Phenyl c-glucoside derivatives, preparation methods and uses thereof |